SLC7A11 and cancer: Immunotherapy-activated CD8+ T cells can release IFN-γ to downregulate the system Xc− functional subunits SLC3A2 and SLC7A11, impeding tumor cells from acquiring cystine and thus leading to lipid peroxidation and ferroptosis in cancer cells [95].